Non-HLA Autoantibody-Driven Lung Allograft Injury, Clinical Course, Autoantibody Profiling, and Response to Steroid and Belatacept
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27219424 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Annika Sundlof und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Temple University Hospital, Philadelphia, PA 19140, USA. Hauptthemen laut MEDLINE: Lung Transplantation, Autoantibodies, Graft Rejection, Abatacept. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The presence of HLA donor-specific antibodies (DSAs), both before and after transplantation, is a well-established risk factor for antibody-mediated rejection (AMR) and poor graft survival. However, emerging evidence suggests that non-HLA antibodies may also provoke immune responses, contributing to rejection. Among these, antibodies targeting the angiotensin II type-1 receptor (AT1R) have been linked to adverse clinical outcomes in kidney and orthotopic heart transplant recipients. This case presents an investigation of non-HLA antibodies in a lung transplant recipient diagnosed with AMR in the absence of HLA DSAs, as well as the use of belatacept as part of a combination immunosuppressive regimen to treat AMR in a lung transplant recipient.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Temple University Hospital, Philadelphia, PA 19140, USA.
- Department of Pathology and Laboratory Medicine, Lewis Katz School of Medicine, Philadelphia, PA 19140, USA.
- Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA.
- Immunogenetics Laboratory, Temple University Hospital, Philadelphia, PA 19140, USA.
- Department of Thoracic Medicine and Surgery, Temple University Hospital, Lewis Katz School of Medicine, Philadelphia, PA 19140, USA.
- Histocompatibility Laboratory Services, American National Red Cross, 180 Rustcraft Road, Dedham, MA 02026, USA.
ORCID-Profile: Rohit Gupta, Kartik Shenoy, Abdelhamid Liacini
Zitieren
APA
Sundlof, A., Taniguchi, M., Gupta, R., Mollaee, M., Cordova, F., Shenoy, K., Geier, S., & Liacini, A. (2026). Non-HLA Autoantibody-Driven Lung Allograft Injury, Clinical Course, Autoantibody Profiling, and Response to Steroid and Belatacept. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27219424
Vancouver
Sundlof A, Taniguchi M, Gupta R, Mollaee M, Cordova F, Shenoy K, et al. Non-HLA Autoantibody-Driven Lung Allograft Injury, Clinical Course, Autoantibody Profiling, and Response to Steroid and Belatacept. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27219424
BibTeX
@article{Sundlof2026,
author = {Sundlof, Annika and Taniguchi, Michiko and Gupta, Rohit and Mollaee, Mehri and Cordova, Francis and Shenoy, Kartik and Geier, Steven and Liacini, Abdelhamid},
title = {Non-HLA Autoantibody-Driven Lung Allograft Injury, Clinical Course, Autoantibody Profiling, and Response to Steroid and Belatacept},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27219424}
}
EUVIMED